Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$994M |
| 2 |
Cigna
CI
|
+$524M |
| 3 |
Microsoft
MSFT
|
+$395M |
| 4 |
Amazon
AMZN
|
+$281M |
| 5 |
CVS Health
CVS
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$918M |
| 2 |
AET
Aetna Inc
AET
|
+$761M |
| 3 |
PX
Praxair Inc
PX
|
+$581M |
| 4 |
COL
Rockwell Collins
COL
|
+$274M |
| 5 |
CA
CA, Inc.
CA
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.98% |
| 2 | Financials | 14.41% |
| 3 | Healthcare | 13.78% |
| 4 | Consumer Discretionary | 9.86% |
| 5 | Industrials | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RSX
3526
DELISTED
VanEck Russia ETF
RSX
| $567K | ﹤0.01% |
30,245
-3,090
| -9% | -$63.5K |
|
3527
ADMA Biologics
ADMA
$2.18B
| $563K | ﹤0.01% |
235,505
-504
| -0.2% | -$2.5K |
|
|
CYBE
3528
DELISTED
Cyberoptics Corp
CYBE
| $560K | ﹤0.01% |
31,768
+1,278
| +4% | +$24.2K |
|
3529
Value Line
VALU
$342M
| $558K | ﹤0.01% |
21,433
-509
| -2% | -$12.7K |
|
|
PCMI
3530
DELISTED
PCM, Inc
PCMI
| $557K | ﹤0.01% |
31,592
+171
| +0.5% | +$3.11K |
|
3531
Corvus Pharmaceuticals
CRVS
$1.16B
| $555K | ﹤0.01% |
151,342
-200
| -0.1% | -$1.36K |
|
3532
Comstock Resources
CRK
$4.22B
| $553K | ﹤0.01% |
121,992
-1,985
| -2% | -$14.6K |
|
3533
Verrica Pharmaceuticals
VRCA
$88M
| $546K | ﹤0.01% |
6,703
+469
| +8% | +$57K |
|
3534
MidCap Financial Investment
MFIC
$797M
| $542K | ﹤0.01% |
43,669
-1,155
| -3% | -$17.6K |
|
3535
Vanguard S&P 500 Growth ETF
VOOG
$27.3B
| $542K | ﹤0.01% |
24,108
-1,566
| -6% | -$37.9K |
|
3536
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.74B
| $535K | ﹤0.01% |
8,422
+225
| +3% | +$14.6K |
|
3537
Mustang Bio
MBIO
$4.47M
| $529K | ﹤0.01% |
240
-1
| -0.4% | -$3.04K |
|
|
LUMO
3538
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $529K | ﹤0.01% |
38,751
-2,434
| -6% | -$42.9K |
|
3539
Vanguard Industrials ETF
VIS
$8.44B
| $526K | ﹤0.01% |
4,366
| – | – |
|
3540
Cohen & Steers REIT and Preferred and Income Fund
RNP
$980M
| $525K | ﹤0.01% |
29,507
-5,648
| -16% | -$103K |
|
3541
Universal Technical Institute
UTI
$1.47B
| $525K | ﹤0.01% |
143,804
+89,307
| +164% | +$254K |
|
3542
Rimini Street
RMNI
$458M
| $519K | ﹤0.01% |
100,710
+2,054
| +2% | +$11.9K |
|
3543
Smart Sand
SND
$197M
| $514K | ﹤0.01% |
231,223
-2,514
| -1% | -$7.92K |
|
3544
Invesco S&P 500 Low Volatility ETF
SPLV
$7.17B
| $514K | ﹤0.01% |
11,024
-321
| -3% | -$15.6K |
|
3545
Apyx Medical
APYX
$146M
| $509K | ﹤0.01% |
78,481
-19,103
| -20% | -$116K |
|
3546
Inseego
INSG
$87.7M
| $508K | ﹤0.01% |
12,236
+488
| +4% | +$18.1K |
|
|
SURF
3547
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $506K | ﹤0.01% |
119,437
+39,964
| +50% | +$309K |
|
|
CYOU
3548
DELISTED
Changyou.com Limited American Depositary Share
CYOU
| $502K | ﹤0.01% |
27,516
-2,422
| -8% | -$40.1K |
|
3549
FuelCell Energy
FCEL
$1.59B
| $495K | ﹤0.01% |
2,494
+65
| +3% | +$18.6K |
|
|
SMI
3550
DELISTED
Semiconductor Manufacturing Intl
SMI
| $495K | ﹤0.01% |
115,873
+22,901
| +25% | +$103K |
|
Similar funds
Northern Trust's Q4 2018 Portfolio in Review
As of Q4 2018, Northern Trust held 4,401 positions worth $357B, down 13% from $409B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2018: portfolio turnover was 5%. Northern Trust opened 95 new positions and exited 125, leaving the 4,401-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
- Northern Trust's largest Q4 2018 buy was Linde: 6,288,266 shares worth $981M.
- Northern Trust added most to Cigna in Q4 2018, an estimated $524M increase.
- Northern Trust's biggest Q4 2018 reduction was FlexShares iBoxx 3-Year Target Duration TIPS Index Fund, cutting an estimated $224M.
- Northern Trust fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $918M.
- Northern Trust's ten largest holdings make up 16% of its $357B portfolio in Q4 2018.
- Northern Trust opened 95 new positions and closed 125 in Q4 2018.
- Northern Trust's portfolio value fell 13% quarter-over-quarter to $357B.
Based on Northern Trust's 13F filing for Q4 2018, filed 12 Feb 2019.